Cover Image
市場調查報告書

心血管手術機器人:全球市場佔有率、策略,及預測 2015-2021年

Cardiac Surgical Robots: Market Shares, Strategies, and Forecasts, Worldwide, 2015-2021

出版商 WinterGreen Research, Inc. 商品編碼 346549
出版日期 內容資訊 英文 223 Pages
訂單完成後即時交付
價格
Back to Top
心血管手術機器人:全球市場佔有率、策略,及預測 2015-2021年 Cardiac Surgical Robots: Market Shares, Strategies, and Forecasts, Worldwide, 2015-2021
出版日期: 2015年12月09日 內容資訊: 英文 223 Pages
簡介

心臟及肺手術機器人設備市場規模,是取代大傷口透過身體的小傷口管理手術的下一代設備,由於系統及設備投入,2014年達到7,220萬美金,至2021年預計達22億美元。

本報告提供全球心臟及肺手術機器人市場相關調查分析、促進市場成長的要素和價格、地區市場相關分析,以及各主要公司及研究機關的腹部手術機器人設備和相關技術的分析、今後的市場預測,為您概述為以下內容。

摘要整理

第1章 心血管手術機器人市場概要、動態

  • 心臟機器人手術臨床應用
  • 介入性心外科醫生的治療、治療
  • 機器人的胸動脈解剖
  • 手術機器人的肺葉切除
  • 機器人的冠狀動脈繞道手術

第2章 心臟、肺手術機器人市場佔有率、預測

  • 心臟、肺手術機器人促進市場成長的要素
  • 心臟、肺手術機器人市場佔有率分析
  • 心臟、肺手術機器人市場預測
  • 心臟、肺手術機器人系統安裝數、治療數:各國
  • 全球醫療手術機器人市場上主要企業
  • 機器人手術設備的價格
  • 心臟、肺機器人手術設備的地區市場區隔
  • 中國的機器人心血管手術

第3章 心血管手術機器人產品的說明

  • Intuitive Surgical
  • Titan Medical
  • Johnson & Johnson
  • MedRobotics
  • Corindus
  • Changzhou Kangxin Medical Instruments Co., Ltd.
  • Guangzhou Baitang Medical Instrument Co., Ltd.

第4章 心血管手術機器人技術、研究

  • Intuitive Surgical 公司的手術用 Da Vinci 電腦技術
  • Intuitive Surgical 公司的 Da Vinci X 手術系統的微創手術
  • 第三方的醫療費償付

第5章 心臟、肺機器人手術機器人企業的說明

  • Chinese Surgical Robots
  • Corindus
  • Freehand
  • Intuitive Surgical
  • Johnson and Johnson / DePuy Synthes
  • Medrobotics
  • Medtronic
  • Meerecompany / Eterne
  • Titan Medical
  • TransEnterix Acquires the ALF-X Surgical Robotic System

圖表清單

目錄
Product Code: SH26554999

Patients for some types of procedures fare better when the heart or lung surgery is done by surgical robots. The documentation of improvements in care delivery, the ability to ensure better outcomes from surgery promise that cardiac and lung surgical robotics is a strong growth market.

Heart disease is still the largest disease worldwide. The issue for cardiac and lung robotic surgery is that so many heart patients exist.

Every leading surgeon working to perform heart and lung robotic surgery has worked to be accepted to practice at a hospital that has those robotic devices. The really talented surgeons depend on hospitals having the cardiac robotic equipment. In order to attract physicians and patients, the hospitals have to purchase the surgical equipment.

The market penetration of the cardiac and lung surgical robots will go to 100 percent in the US top hospitals within five years. As the surgeons migrate to the places that have the robotic surgical equipment, other hospitals and their potential patient populations notice. If the hospital does not have the surgical robotic equipment, it will not have any surgeons, this is a bad situation for a hospital. The cardiac and lung robotic surgical equipment permits better surgery and the surgeons and patients know this.

Cardiac and lung robotic surgery is poised to eclipse open surgery. It is used in the categories of lobectomy, thoracic revascularization, and mitral valve repair surgery. Surgical robots are positioned to become the standard of care for hospitals in the delivery of some heart surgery. The emerging group of several surgical robotic companies will collectively have enough marketing dollars and enough marketing clout to drive replacement of virtually all open cardiac and lung surgery.

Larger hospitals that can afford the expenditure are adopting heart and lung robotic surgical devices to improve their outcomes numbers. Hospitals are measured on outcomes, robots for surgery, when used by a trained physician are improving outcomes significantly. Hospital robotic systems have an emphasis on outcomes improvement during surgery. This has resulted in investment in robotics technology that is useful, and achieves positive patient outcomes.

Technology is enhancing a wide variety of procedures in many cardiac surgical specialties. Cardiac and thoracic surgeons at leading hospitals use robotic surgical systems increasingly. The aim is to perform more of the one-hundred thousand MIS surgical procedures of various types using robots. The surgeries performed by robot include cardiothoracic and vascular surgery. These surgical applications are cleared by the FDA.

The technology uses metal tubes attached to the arms are inserted through the ports, and the cutting and visualization instruments are introduced through the tubes into the patient's body. The surgeon performs the procedure while sitting at a console, manipulating the instrument controls and viewing the operation through a vision system. When a surgeon needs to change an instrument the instrument is withdrawn from the surgical field using the controls at the console and the nursing assistants switch instruments as per the physician instruction. This is done many times during an operation.

The cardiac and lung surgical robot market is characterized enormous variety and innovation. A surgical robot recurring revenue business model is essentially a large one time purchase for a system complimented by replaceable or disposable instruments that cumulatively make the market a much larger and sustainable ongoing market. Vendors make money from the one time sale of a system and recurring revenue from sale of devices used in every operation.

Initially, a vendor sells and installs the surgical system into new customer accounts. Once systems are sold into customer accounts, the vendor generates recurring revenue as customers use the system to perform surgery. To do cardiac and lung robotic surgeries, the customers need to buy and consume instruments and accessory products. Vendors also generate recurring revenue from system service.

According to Susan Eustis, lead author of the study, "Existing open cardiac and lung surgery can be replaced in some part by robotic surgery during the forecast period. Cardiac and lung robotic surgical approaches complement existing open surgery techniques. Soon, all surgery will be undertaken with at least come aspects of robotic surgery replacing or complementing open surgery."

The aging US population has supported demand, since the occurrence of health issues that require medical devices is higher in the elderly population. Buoyed by strong demand and sales, industry profit margins have increased considerably during the past five years.

Hospitals are adopting robotic surgical devices to improve their outcomes numbers. Hospitals are measured on outcomes, robots for surgery, when used by a trained physician are improving outcomes significantly. Hundreds of universities worldwide have research programs in robotics and many are awarding degrees in robotics. These "roboticists" are increasingly being hired by Global 2000 organizations to link mobile robots (mobile computers) into existing IT systems.

Robot-assisted surgery gives the surgeon better control over the surgical instruments and a better view of the surgical site. Surgeons no longer have to stand throughout the surgery and do not tire as quickly. Hand tremors are filtered out by the robot's computer software. The surgical robot can continuously be used by rotating surgery teams. 3D viewing of the surgical site on a large screen improves visualization of the surgical operating field.

Cardiac and lung surgical robot device markets at $72.2 million in 2014 are anticipated to reach $2.2 billion by 2021 as next generation devices, systems, and instruments are introduced to manage surgery through small ports in the body instead of large open wounds.

The complete report provides a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players' success, challenges, and strategies in each segment and sub-segment. The reports cover markets for Cardiac and Lung robotic surgery medical specialties and sub-specialties.

Table of Contents

Heart and Lung Surgical Robot Executive Summary

  • Heart and Lung Surgical Robot Market Driving Forces
    • Surgical Robotics Market Driving Forces
    • Cardiac Surgical Robot Key Procedures As Elements Of Strategy
  • Cardiac and Lung Surgical Robots Market Share Analysis
  • Cardiac and Lung Surgical Robot Market Forecasts

1. Cardiac Surgical Robot Market Description and Market Dynamics

  • 1.1 Cardiac Robotic Surgical Clinical Applications
    • 1.1.1 Robotic Cardiothoracic Surgery
    • 1.1.2 Mitral Valve Repairs Are Preferred Over Mitral Valve Replacement
    • 1.1.3 Mitral Valve Repair
    • 1.1.4 Mitral Valve Replacement Possible Complications
  • 1.2 Interventional Cardiologists Treatments and Procedures
  • 1.3 Robotic Internal Thoracic Artery Dissection
    • 1.3.1 Robotic Thoracoscopy
    • 1.3.2 Cardiothoracic Surgery
  • 1.4 Surgical Robotic Lobectomy
  • 1.5 Robotic Coronary Artery Bypass

2. Heart and Lung Surgical Robot Market Shares and Market Forecasts

  • 2.1 Heart and Lung Surgical Robot Market Driving Forces
    • 2.1.1 Surgical Robotics Market Driving Forces
    • 2.1.1 Cardiac Surgical Robot Key Procedures As Elements Of Strategy
  • 2.2 Cardiac and Lung Surgical Robots Market Share Analysis
    • 2.2.1 Intuitive Surgical da Vinci™ Surgical System Is Food and Drug Administration (FDA) Approved Cardiac and Lung Robotic System
    • 2.2.2 Corindus
    • 2.2.3 MedRobotics
  • 2.3 Cardiac and Lung Surgical Robot Market Forecasts
  • 2.4 Cardiac and Lung Surgical Robot Installed Systems and Procedure Volumes by Country
  • 2.5 Key Players In The Global Medical Surgical Robots Market
  • 2.6 Robotic Surgery Equipment Prices
    • 2.1.2 Intuitive Surgical da Vinci Surgical System Prices
  • 2.7 Cardiac and Lung Robotic Surgery Equipment Regional Market Segments
    • 2.7.1 Intuitive Surgical Regional Revenue
    • 2.7.2 Intuitive Surgical European Demand
    • 2.7.3 Intuitive Surgical in Japan
    • 2.7.4 U.S. Robotic Surgical Procedures
    • 2.7.5 BRIC (Brazil, Russia, India, China) countries
    • 2.7.6 Aging Taiwanese Population
    • 2.7.7 Korea Focusing On Creating A Growth Engine In Research & Development 74
    • 2.7.8 Korea
    • 2.7.9 Brazil
    • 2.7.10 Chinese Imported Surgical Robots
    • 2.7.11 Chinese Development of Surgical Robots
  • 2.8 Chinese Robotic Cardiac Surgery
    • 2.8.1 Chinese Robotic Cardiac Team Recognized As One Of World's Best

3. Cardiac Surgical Robots Product Descriptions

  • 3.1 Intuitive Surgical Cardiothoracic Surgeries
    • 3.1.1 Intuitive Surgical da Vinci Surgical System
    • 3.1.2 Intuitive Surgical Da Vinci Minimally Invasive Surgical Product
    • 3.1.3 Intuitive Surgical Cardiac Surgery
    • 3.1.4 Intuitive Surgical da Vinci Surgical System Components
    • 3.1.5 Intuitive Surgical Patient-Side Cart and Electromechanical Surgical Arms 94
    • 3.1.6 Intuitive Surgical 3-D Vision System
    • 3.1.7 Intuitive Surgical Firefly Fluorescence Imaging
    • 3.1.8 Intuitive Surgical. da Vinci Surgical System EndoWrist® Instruments
    • 3.1.9 Intuitive Surgical Instruments and Accessories
    • 3.1.10 Intuitive Surgical da Vinci Single-Site
    • 3.1.11 Intuitive Surgical EndoWrist One Vessel Sealer
    • 3.1.12 Intuitive Surgical da Vinci Skills Simulator
  • 3.2 Titan Medical
  • 3.3 Johnson & Johnson
    • 3.3.1 Johnson & Johnson Ethicon
  • 3.4 MedRobotics
    • 3.4.1 Medrobotics Flex® Retractor
    • 3.4.2 Medrobotics Flexible Robot Platform
    • 3.4.3 Medrobotics Snakelike Robots for Oropharynx, Hypopharynx and Larynx Surgery 116
  • 3.5 Corindus
    • 3.5.1 CorPath Robotic Angioplasty
    • 3.5.2 Corindus Command. Control CorPath® 200 System
    • 3.5.3 Corindus Standard in Precision PCI
    • 3.5.4 Robotic Angioplasty / Interventional Cardiology
  • 3.6 Changzhou Kangxin Medical Instruments Co., Ltd.
  • 3.7 Guangzhou Baitang Medical Instrument Co., Ltd.

4. Cardiac Surgical Robots Technology and Research

  • 4.1 Intuitive Surgical Da Vinci Computerized Technology For Surgery
  • 4.2 Intuitive Surgical da Vinci Xi Surgical System Minimally Invasive Surgery
    • 4.2.1 Intuitive Surgical da Vinci Surgical System
  • 4.3 Third Party Reimbursement

5. Cardiac and Lung Surgical Robots Company Descriptions

  • 5.1 Chinese Surgical Robots
  • 5.2 Corindus
    • 5.2.1 Corindus Benefits of CorPath Robotic-Assisted PCI
    • 5.2.2 Corindus Improves Staff Position in the Room
  • 5.3 Freehand
    • 5.3.1 Freehand 2010 / Prosurgics
  • 5.4 Intuitive Surgical
    • 5.4.1 Intuitive Surgical Robotics da Vinci® Surgical System
    • 5.4.2 Intuitive Surgical Robotics da Vinci Surgical System Xi
    • 5.4.3 Intuitive Surgical Business Strategy
    • 5.4.4 Intuitive Surgical Systems
    • 5.4.5 Intuitive Surgical Patient Value As Equal To Procedure Efficacy / Invasiveness 157
    • 5.4.6 Intuitive Surgical Business Model
    • 5.4.7 Intuitive Surgical Revenue
    • 5.4.8 Intuitive Surgical Regulatory Activities
    • 5.4.9 Intuitive Surgical Economic Environment.
  • 5.5 Johnson and Johnson / DePuy Synthes
    • 5.5.1 Google Collaborating With Johnson & Johnson To Develop Surgical Robots 162
    • 5.5.2 DePuy
    • 5.5.3 Johnson & Johnson
    • 5.5.4 Johnson & Johnson / Ethicon
  • 5.6 Medrobotics
    • 5.6.1 Medrobotics Closes On $10 Million Financing
    • 5.6.2 Medrobotics Several Generations Of Snake Robot Platforms
    • 5.6.3 Medrobotics Advances Clinical Development of Snake Robot for Surgery 168
    • 5.6.4 Medrobotics Positioning
    • 5.6.5 Medrobotics Cardiac Surgery Gold Standard
    • 5.6.6 Medrobotics Snake Robot Technologies For Use In A Wide Range Of Surgical And Interventional Applications
    • 5.6.7 Medrobotics Technology & Research Center
  • 5.7 Medtronic
    • 5.7.1 Medtronic PLC
    • 5.7.2 Medtronic O-arm Surgical Imaging System
  • 5.8 Meerecompany / Eterne
  • 5.9 Titan Medical
    • 5.9.2 Titan Medical General Surgery Robot Market Opportunities
    • 5.9.3 Titan Medical Robotic Surgery Target Opportunity
  • 5.10 TransEnterix Acquires the ALF-X Surgical Robotic System
    • 5.10.2 TransEnterix Strategic Positioning
    • 5.10.3 TransEnterix
    • 5.10.4 TransEnterix / Sofar
    • 5.11 Surgical Robot Companies

List of Tables and Figures

  • Table ES-1 Innovative Surgical Robot Features
  • Table ES-2 Surgical Robotics Market Driving Forces
  • Table ES-3 Surgical Robot Market Positioning
  • Table ES-4 Cardiac and Lung Surgical Robot Medical Sub-Specialties
  • Figure ES-5 Cardiac and Lung Surgical Robots Market Shares, Shipments, Dollars, Worldwide 2014 31
  • Figure ES-6 Cardiac and Lung Surgical Robot Systems Forecasts, Dollars, Worldwide, 2015-2021 34
  • Table 1-1 Cardiac Conditions Requiring Surgery
  • Table 1-2 Intuitive Surgical Robotic Cardiac Procedures
  • Table 1-3 Robotic Surgery Surgical Specialty Focus
  • Table 1-4 Mitral Valve Problem Description
  • Table 1-5 Causes Of Mitral Valve Problems
  • Table 1-6 Mitral Valve Replacement Possible Complications
  • Table 1-7 Factors That May Increase The Risk Of Complications With Heart Surgery
  • Table 1-8 Physician-Patient Mitral Valve Heart Valve Assessment Program Aspects
  • Table 1-9 Catheter-Based Valve Disease Procedures
  • Table 1-10 Cardiac Surgeon Open Surgical Procedures:
  • Table 2-1 Innovative Surgical Robot Features
  • Table 2-2 Surgical Robotics Market Driving Forces
  • Table 2-3 Surgical Robot Market Positioning
  • Table 2-4 Cardiac and Lung Surgical Robot Medical Sub-Specialties
  • Figure 2-5 Cardiac and Lung Surgical Robots Market Shares, Shipments, Dollars, Worldwide 2014 56
  • Table 2-6 Cardiac and Lung Surgical Robot Market Shares, Dollars, Worldwide, 2014
  • Figure 2-7 Cardiac and Lung Surgical Robot Systems Forecasts, Dollars, Worldwide, 2015-2021 63
  • Table 2-8 Heart and Lung Surgical Robot Market Segment Forecasts, Dollars and Units, Worldwide, 2015-2021
  • Table 2-9 Number Intuitive Surgical Cardio/Thoracic Robotic Procedures, Regional Analysis by Procedure Type, 2014
  • Table 2-10 Open and Robotic Surgeries: Cardio Thoracic Procedure Forecasts, Number US and Worldwide, 2015-2021
  • Table 2-11 Cardio Thoracic Robotic Surgery Procedures By Country, 2014
  • Table 2-11 (Continued) Abdominal / Cardio Thoracic Robotic Surgery Procedures By Country, 2014
  • Table 2-12 Cardio Thoracic Robotic Surgery Procedure Forecasts, Lobectomy, Mitrial Valve Repair, Vascular Surgery, Number of Procedures, Worldwide, 2015-2021
  • Figure 2-13 Cardiac and Lung Surgical Robot Regional Market Segments, Dollars, 2014
  • Figure 2-14 Cardiac and Lung Surgical Robot Regional Market Segments, 2014
  • Figure 2-15 China Robotic Cardiac Surgery
  • Figure 3-1 Intuitive Surgical Integrated Sub - Systems
  • Figure 3-2 Intuitive Surgical da Vinci Surgical System
  • Figure 3-3 Intuitive Surgical Da Vinci Surgery
  • Table 3-4 Intuitive Surgical Da Vinci Surgical System Components
  • Table 3-5 Intuitive Surgical Cardiac Conditions Addressed
  • Table 3-6 Minimally Invasive Da Vinci Surgery Benefits To Cardiac Patients
  • Figure 3-7 Intuitive Surgical da Vinci System State-Of-The-Art Robotic Surgical Platform
  • Table 3-8 Intuitive Surgical da Vinci Si Surgical System Core Benefits:
  • Figure 3-9 Intuitive Surgical da Vinci SI Surgical System Dual Console Used For Training And Collaboration
  • Figure 3-10 Intuitive Surgical. da Vinci Surgical System Vision System
  • Table 3-11 Intuitive Surgical da Vinci Xi Surgical System Surgeon Console Features
  • Figure 3-12 Intuitive Surgical. da Vinci Surgical System Surgeon Console
  • Figure 3-13 Intuitive Surgical. da Vinci Surgical System Patient-Side Cart
  • Figure 3-14 Intuitive Surgical. da Vinci Surgical System EndoWrist® Instruments
  • Table 3-15 Intuitive Surgical da Vinci Surgical System Features
  • Table 3-16 Advantages of Intuitive Surgical Cardio Thoracic Robotic Surgery
  • Table 3-17 Surgical Robot Cardiothoracic Conditions Treated
  • Figure 3-18 Intuitive Surgical da Vinci Surgical System, Surgeon Operates Seated Comfortably At A Console
  • Figure 3-19 Intuitive Surgical da Vinci Surgical System Patient Side Cart
  • Figure 3-20 Titan Single Port Orifice Robotic Technology SPORT™ Surgical System
  • Figure 3-21 Titan SPORT™ Surgical System:
  • Table 3-22 Titan MedicalSPORT™ Surgical System Patient Benefits:
  • Table 3-23 Titan MedicalSPORT™ Surgical System Surgeon Benefits:
  • Table 3-24 Johnson & Johnson Ethicon Minimally Invasive Procedures As They Apply To Specific Conditions
  • Figure 3-25 Medrobotics Flex® Retractor
  • Figure 3-26 Medrobotics Snakelike Robot Tested for Heart Surgery
  • Table 3-27 Medrobotics Medical Field Target Markets
  • Figure 3-28 Corindus CorPath Robotic Angioplasty
  • Figure 3-29 Corindus Command. Control CorPath® 200 System
  • Figure 3-30 Corindus Precise Robotic Movement And Device Fixation
  • Table 3-31 Corindus Robotic-Assisted Control Benefits
  • Figure 3-32 Occupational Hazards in Cath Lab
  • Figure 3-33 Corindus Robotic Assisted PCI
  • Figure 4-1 Intuitive Surgical da Vinci Surgical System
  • Figure 5-1 Tianjin Municipality Micro Hand A Chinese Surgical Robots
  • Figure 5-2 China's First Surgical Robot For Minimally Invasive Surgery At Tianjin Municipality
  • Table 5-3 Benefits of Corindus CorPath Robotic-Assisted PCI
  • Figure 5-4 Corindus CorPath Benefits
  • Table 5-5 Corindus Benefits of CorPath Robotic-Assisted PCI
  • Figure 5-6 Corindus Step Away From Radiation Source During Robotic PCI
  • Table 5-7 Corindus CorPath Robotic-Assisted PCI Mean Radiation Dose (per procedure) by Position (μSV)2
  • Figure 5-8 Intuitive Surgical Platform, daVinci Xi
  • Table 5-9 Intuitive Surgical Strategy To Improve Candidate Surgical Procedures
  • Table 5-10 Johnson and Johnson Family of Companies Comprises:
  • Table 5-11 Medrobotics Positioning 2015
  • Table 5-12 Medrobotics Cardiac Surgery Improvements
  • Table 5-12 Medrobotics Snake Robot Technologies For Use In A Wide Range Of Surgical And Interventional Applications
  • Table 5-13 Medrobotics Snake Robot Technologies Specialist Areas Served
  • Table 5-14 Medtronic O-arm® Surgical Imaging StealthStation® Navigation Functions
  • Table 5-15 Medtronic O-arm Surgical Imaging System Benefits
  • Table 5-16 Medtronic O-arm Surgical Imaging System
  • Table 5-17 Medtronic O-arm Surgical Imaging System Benefits
  • Figure 5-18 Medtronic Lumbar Imaging
  • Table 5-19 Titan Medical Investment Summary
  • Figure 5-20 Titan Medical Business Goals and Timetable
  • Figure 5-21 Titan Medical Describes Robotic General Surgery Market Potential
  • Figure 5-22 Titan Medical Robotic Surgery Target Opportunity
  • Table 5-23 TransEnterix Strategic Positioning
  • Figure 5-24 TELELAP Robotic Surgical Unit
  • Figure 5-25 Telelap ALF-X Robotic Surgery
  • Figure 5-26 TELELAP ALF-X Breaking Barriers Supporting Precision
Back to Top